U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C21H35N2O3.Cl
Molecular Weight 398.967
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of LAPYRIUM CHLORIDE

SMILES

[Cl-].CCCCCCCCCCCC(=O)OCCNC(=O)C[N+]1=CC=CC=C1

InChI

InChIKey=HPKFFZSXDWPVLX-UHFFFAOYSA-N
InChI=1S/C21H34N2O3.ClH/c1-2-3-4-5-6-7-8-9-11-14-21(25)26-18-15-22-20(24)19-23-16-12-10-13-17-23;/h10,12-13,16-17H,2-9,11,14-15,18-19H2,1H3;1H

HIDE SMILES / InChI

Description
Curator's Comment: description was created based on several sources, including https://www.drugs.com/international/lapyrium-chloride.html | https://www.ncbi.nlm.nih.gov/pubmed/22426733 | https://www.ncbi.nlm.nih.gov/pubmed/6713839

Lapyrium, or lapirium, as the chloride salt lapirium chloride (INN) or lapyrium chloride (USAN), is a cationic surfactant that is used in cosmetic personal care products as a biocide and antistatic agent. A 50% solution of Lapyrium Chloride produced slight to moderate erythema. Lapyrium is also used in waste-water treatment and corrosion inhibition formulations.

Originator

Approval Year

1964
102
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Curative
Withdrawn
VIRAC REX

Approved Use

Unknown
Sourcing

Sourcing

Vendor/AggregatorIDURL
ABI Chem
AC1L2KT2
ABI Chem
AC1Q5PN8
AK Scientific
9475AB
Alfa Chemistry
ACM6272748
BLD Pharm
BD01272406
http://www.bldpharm.com/products/109260-82-4.html
BOC Sciences
6272-74-8
BioSynth
W-104962
BlocksMatrix Scientific
99527
Compound Cloud
22659
Compound Cloud
22660
Hairui
HR133019
NCI Plated 2007
33659
Norris Pharm
NSZB-A026155
Smolecule
S532490
http://www.smolecule.com/products/s532490
THE BioTek
bt-272552
https://www.thebiotek.com/product/inhibitors/bt-272552
Tetrahedron
TS69219
ZINC
ZINC000008214591
http://zinc15.docking.org/substances/ZINC000008214591
eMolecules
44690858
PubMed

PubMed

TitleDatePubMed
Scapular reactivity to contact irritants: application-time and area variations.
1984 Apr-Jun
Intraregional variation between contact irritant patch test sites.
1984 Feb
Patents

Patents

US2928772
2

Sample Use Guides

In Vivo Use Guide
Twenty-two diurnally active, fair-skinned, male volunteers were repeatedly patch tested with 10, 15 and 20% lapyrium chloride (LC) for 5 consecutive days.
Route of Administration: Topical
In Vitro Use Guide
Unknown
Name Type Language
LAPYRIUM CHLORIDE
INCI   MI   ORANGE BOOK   USAN  
INCI   USAN  
Official Name English
1-[[(2-Hydroxyethyl)carbamoyl]methyl]pyridinium chloride laurate (ester)
Common Name English
LAPIRIUM CHLORIDE
INN   WHO-DD  
INN  
Official Name English
LAPYRIUM CHLORIDE COMPONENT OF VIRAC REX
Common Name English
Lapirium chloride [WHO-DD]
Common Name English
1-((2-DODECANOYLOXYETHYLCARBAMOYL)METHYL)PYRIDINIUM CHLORIDE
Systematic Name English
N-(LAUROYLCOLAMINOFORMYLMETHYL)PYRIDINIUM CHLORIDE
Common Name English
lapirium chloride [INN]
Common Name English
LAPYRIUM CHLORIDE [USAN]
Common Name English
LAPYRIUM CHLORIDE [MI]
Common Name English
NSC-33659
Code English
PYRIDINIUM, 1-(2-OXO-2-((2-((1-OXODODECYL)OXY)ETHYL)AMINO)ETHYL)-, CHLORIDE
Systematic Name English
E-607
Brand Name English
LAPYRIUM CHLORIDE [ORANGE BOOK]
Common Name English
LAPYRIUM CHLORIDE [INCI]
Common Name English
EMCOL E-607
Brand Name English
VIRAC REX COMPONENT LAPYRIUM CHLORIDE
Common Name English
Classification Tree Code System Code
EPA PESTICIDE CODE 69131
Created by admin on Sat Dec 16 16:58:52 GMT 2023 , Edited by admin on Sat Dec 16 16:58:52 GMT 2023
NCI_THESAURUS C28394
Created by admin on Sat Dec 16 16:58:52 GMT 2023 , Edited by admin on Sat Dec 16 16:58:52 GMT 2023
Code System Code Type Description
PUBCHEM
22659
Created by admin on Sat Dec 16 16:58:52 GMT 2023 , Edited by admin on Sat Dec 16 16:58:52 GMT 2023
PRIMARY
FDA UNII
732T8851QH
Created by admin on Sat Dec 16 16:58:52 GMT 2023 , Edited by admin on Sat Dec 16 16:58:52 GMT 2023
PRIMARY
ECHA (EC/EINECS)
228-464-1
Created by admin on Sat Dec 16 16:58:52 GMT 2023 , Edited by admin on Sat Dec 16 16:58:52 GMT 2023
PRIMARY
EVMPD
SUB08404MIG
Created by admin on Sat Dec 16 16:58:52 GMT 2023 , Edited by admin on Sat Dec 16 16:58:52 GMT 2023
PRIMARY
NSC
33659
Created by admin on Sat Dec 16 16:58:52 GMT 2023 , Edited by admin on Sat Dec 16 16:58:52 GMT 2023
PRIMARY
CAS
6272-74-8
Created by admin on Sat Dec 16 16:58:52 GMT 2023 , Edited by admin on Sat Dec 16 16:58:52 GMT 2023
PRIMARY
CAS
1341-07-7
Created by admin on Sat Dec 16 16:58:52 GMT 2023 , Edited by admin on Sat Dec 16 16:58:52 GMT 2023
SUPERSEDED
NCI_THESAURUS
C87262
Created by admin on Sat Dec 16 16:58:52 GMT 2023 , Edited by admin on Sat Dec 16 16:58:52 GMT 2023
PRIMARY
DRUG CENTRAL
3314
Created by admin on Sat Dec 16 16:58:52 GMT 2023 , Edited by admin on Sat Dec 16 16:58:52 GMT 2023
PRIMARY
MERCK INDEX
m6691
Created by admin on Sat Dec 16 16:58:52 GMT 2023 , Edited by admin on Sat Dec 16 16:58:52 GMT 2023
PRIMARY Merck Index
ChEMBL
CHEMBL1201786
Created by admin on Sat Dec 16 16:58:52 GMT 2023 , Edited by admin on Sat Dec 16 16:58:52 GMT 2023
PRIMARY
INN
3204
Created by admin on Sat Dec 16 16:58:52 GMT 2023 , Edited by admin on Sat Dec 16 16:58:52 GMT 2023
PRIMARY
SMS_ID
100000082576
Created by admin on Sat Dec 16 16:58:52 GMT 2023 , Edited by admin on Sat Dec 16 16:58:52 GMT 2023
PRIMARY
DRUG BANK
DBSALT002416
Created by admin on Sat Dec 16 16:58:52 GMT 2023 , Edited by admin on Sat Dec 16 16:58:52 GMT 2023
PRIMARY
EPA CompTox
DTXSID5042085
Created by admin on Sat Dec 16 16:58:52 GMT 2023 , Edited by admin on Sat Dec 16 16:58:52 GMT 2023
PRIMARY
ACTIVE MOIETY
Structure of LAPYRIUM
SUBSTANCE RECORD
Structure of LAPYRIUM CHLORIDE
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966